Inhaled corticosteroids' effect on COVID-19 patients: A systematic review and meta-analysis of randomized controlled trials.
Yasra BadiMohamed HammadAbdelrahman G TawfikMona Muhe Eldeen EshagMahmoud M ElhadyKhaled Mohamed RagabAnas Zakarya NoureldenMohamed Hesham GamalAhmed Hashem FathallahPublished in: Canadian journal of respiratory therapy : CJRT = Revue canadienne de la therapie respiratoire : RCTR (2023)
We concluded that the use of ICS decreased patient LOS and improved COVID-19-related symptoms. INC may have a role in improving the smell score. Therefore, using INC and ICS for two weeks or more may prove beneficial. Current data do not demonstrate an effect on mortality or time to sustained self-reported cure. However, the evidence is inconclusive, and more studies are needed for more precise data.